812.21 HMGLPTHLATER

CH

Art. 87 Legge federale del 15 dicembre 2000 sui medicamenti e i dispositivi medici (LATer) - Altri reati

LATer; Capitolo 8: Disposizioni penali

Apri la fonte ufficiale Atto completo (141 Articoli) Versione Markdown leggibile dalle macchine (.md)

Art. 87 LATer · Altri reati

È punito con la multa fino a 50 000 franchi chiunque intenzionalmente: a. fabbrica, immette in commercio, importa, esporta agenti terapeutici o sostanze ausiliarie farmaceutiche che non corrispondono ai requisiti fissati nella farmacopea, o ne fa commercio all’estero; b. infrange le disposizioni concernenti la pubblicità di medicamenti; c. viola gli obblighi di notifica, di registrazione e di pubblicazione previsti dalla presente legge; d. viola obblighi di caratterizzazione, contabilità, conservazione e collaborazione; e. viola l’obbligo del segreto, per quanto non siano violati gli articoli 162, 320 o 321 del Codice penale ; f. commette un’infrazione ai sensi dell’articolo 86 capoverso 1 lettere a–g, sempre che l’infrazione concerna agenti terapeutici destinati esclusivamente a uso proprio, medicamenti in vendita libera o dispositivi medici della classe I conformemente all’allegato IX della direttiva 93/42/CEE ; g. viola una decisione notificatagli con la comminatoria della pena prevista dal presente articolo; h. viola l’obbligo di trasparenza di cui all’articolo 56.

Se nei casi di cui al capoverso 1 lettere a, b, e ed f l’autore agisce per mestiere, la pena è una pena pecuniaria.

Se l’autore agisce per negligenza, la pena è della multa fino a 20 000 franchi.

Il tentativo e la complicità sono punibili.

Le contravvenzioni e le pene per contravvenzioni si prescrivono in cinque anni.

Nei casi particolarmente lievi si può rinunciare al perseguimento penale e alla punizione.

← Art. 86 LATer Legge federale del 15 dicembre 2000 sui medicamenti e i dispositivi medici (LATer) - Scopo Art. 88 LATer →

Decisioni giudiziarie che applicano questa disposizione (70)

UE230315 · zh (Art. 87 Abs. 6 HMG)

Importation of Controlled Substance for Medical Use as "Particularly Light Case"

The court confirmed the prosecutor's decision to discontinue the proceedings based on this provision, which allows for abstention from prosecution in particularly minor cases.

SB240314 · zh (Art. 87 Abs. 1 lit. f HMG in Verbindung mit Art. 86 Abs. 1 lit. a HMG)

Appeal Regarding Drug Trafficking Conviction, Sentencing, and Fines

The court confirmed the conviction for violating the Medicinal Products Act (though it waived punishment for this offense in the final order).

SB240314 · zh (Art. 87 Abs. 6 HMG)

Appeal Regarding Drug Trafficking Conviction, Sentencing, and Fines

The court explicitly decided to waive punishment for the violation of the Medicinal Products Act based on this provision.

2023.12.19.sr.1 · bl (Art. 87 Abs. 1 lit. f HMG)

Narcotics Act Case Discontinued Due to Procedural Limitations

Cited in the first instance judgment regarding the conviction for violation of the HMG.

360----------- · vd (art. 87 al. 1 let. f LPTh)

Sexual Coercion Conviction Upheld, Drug/Therapeutic Product Convictions Overturned, Sentence Modified

Cited in the grounds section ('Par ces motifs') regarding the acquittal from the contravention to LPTh (ordre I), although the final acquittal is based on the reasoning that the exemption for personal use applies (art. 36 al. 1 aOAMéd mentioned later).

C-2825/2020 (Art. 87 Abs. 1 Bst. g HMG)

Swissmedic Advertising Ban Appeal Mooted by Revised Decision

Cited in the original order of Swissmedic as the legal basis for penalties for violations of advertising regulations.

2021.05.07.sr.1 · bl (Art. 87 Abs. 1 lit. f HMG i. V. m. aArt. 86 Abs. 1 lit. b und c HMG, aArt. 5 lit. a HMG, aArt. 9 Abs. 2 lit. a HMG, Art. 49 Abs. 1 StGB, Art. 106 Abs. 2 StGB sowie Art. 333 Abs. 3 und 4 StGB)

Reckless Indirect Homicide and Drug Law Violations

This provision was used to convict the defendant for the offenses of manufacturing a medicinal product without a license and dispensing medicinal products without authorization.

460.20.23 · bl (Art. 87 Abs. 1 lit. f HMG)

Suicide Capacity and Reckless Harm Ruling

Used to find the defendant guilty of the offense of storing a unlawfully manufactured and thus unusable and non-marketable medicinal product, as this provision covers violations without concrete endangerment.

P/857/2017 · ge (art. 87 al. 1 let. f de la Loi fédérale sur les médicaments et les dispositifs médicaux (LPTh))

Unauthorized Medical Practice and Insurance Fraud Conviction Upheld

The appellant was convicted of illegally prescribing prescription drugs for the period after February 5, 2015, based on this article.

A-3334/2019 (Art. 87 al. 1 let. c LPTh)

Access to Prosthetic Device Incident Reports, Including User and Manufacturer Data

Specifies sanctions (fines) for violations of reporting obligations.

SST.2019.231 · ag (Art. 87 Abs. 1 lit. f HMG)

United States v. Jones

Procedural rule for the suspension of proceedings due to statute of limitations.

P/857/2017 · ge (art. 87 al. 1 let. f de la Loi fédérale sur les médicaments et les dispositifs médicaux (LPTh))

Unauthorized Practice of Medicine and Insurance Fraud Involving Forgery

XA____ was found guilty of an offense under this article for the period after February 5, 2015.

SK1 2018 23 · gr (Art. 26 HMG i.V.m. Art. 87 Abs. 1 lit. f HMG)

Medical Practitioner Self-Dispensing Violations Appeal

The appellant was convicted of repeated violation of Art. 26 HMG in connection with Art. 87 para. 1 lit. f HMG.

C-6485/2016 (Art. 87 Abs. 1 Bst. g HMG)

Company Barred from Manufacturing Transplant Products Without Permits

Cited in the dispositive as the legal basis for potential fines for non-compliance with the prohibitions.

C-669/2016 (Art. 87 al. 1 let. g LPTh)

Foundation v. Regulatory Authority: Mobile App Classified as Medical Device

Cited as a potential penalty for non-compliance with the order.